Clinical trials - Press Releases

Date	Title	Company
17-Jan-2023	Greenphire Appoints Owen Newman as Chief Financial Officer to Accelerate Company Growth	Greenphire
17-Jan-2023	UK ATMP Clinical Trials Database 2022: Number of Advanced Therapy Medicinal Product clinical trials in the UK continues to increase year-on-year	The Cell and Gene Therapy Catapult (CGT Catapult)
17-Jan-2023	SolasCure announces publication of toxicology and pre-clinical research programme as final patient is enrolled into pivotal clinical trial	SolasCure
17-Jan-2023	ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002	ImmunOs Therapeutics
11-Jan-2023	HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)	HighTide Therapeutics Inc.
11-Jan-2023	BioXcel Therapeutics Announces Promising Top-Line Results from Phase 2 Trial of BXCL701 in Aggressive Form of Rare Prostate Cancer	BioXcel Therapeutics
11-Jan-2023	Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD)	Zenas BioPharma
11-Jan-2023	UK independent clinical trial sites running research on new medicines continue to prosper despite the decline at NHS sites	Panthera
11-Jan-2023	Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program	Avance Clinical
11-Jan-2023	Ethics Approval granted for significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial	Chanelle McCoy Health
10-Jan-2023	Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark	Phastar
10-Jan-2023	Positive Initial Data Analysis in POLB 001 LPS Challenge Trial	Poolbeg Pharma Plc
06-Jan-2023	Egnyte to provide early-stage life science startups a year of Egnyte’s platform at no cost	Egnyte
06-Jan-2023	atai Life Sciences Announces Results from Phase 2a Trial of PCN-101 (R-ketamine) for Treatment-Resistant Depression	atai Life Sciences
06-Jan-2023	Transgene Receives Approval to Start a Phase I Trial of TG6050, a Novel IL-12-Armed Oncolytic Virus Given by Intravenous Administration	Transgene
06-Jan-2023	HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations	HighTide Therapeutics Inc.
05-Jan-2023	Nouscom Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate NOUS-209 in combination with KEYTRUDA® (pembrolizumab) in a Phase 2 Randomized Trials in dMMR/MSI-High Metastatic Colorectal Cancer	Nouscom
05-Jan-2023	Sosei Heptares Notes its Partner Tempero Bio has Received FDA Clearance to Advance Clinical Development of TMP-301 for Treatment of Alcohol and Substance Use Disorders	Sosei Heptares
05-Jan-2023	STEMart Introduces API Impurity Identification Services for Medical Devices	STEMart
04-Jan-2023	ISA Pharmaceuticals and Cancer Focus Fund Announce $5 Million Investment to Support First-in-Human Trial of ISA’s Novel Immunotherapy ISA103 in Uveal Melanoma	ISA Pharmaceuticals